Related Experiment Video
Updated: Apr 21, 2026
11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
5.8K
Primary biliary cirrhosis and liver transplantation
Nobuhisa Akamatsu1, Yasuhiko Sugawara2
1Department of Hepato-biliary-pancreatic Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan; ; Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Intractable & Rare Diseases Research
|October 25, 2014
Summary
Primary biliary cirrhosis (PBC) is an autoimmune liver disease affecting women. While ursodeoxycholic acid improves survival, liver transplantation is crucial for non-responders, though PBC can recur post-transplant.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Primary biliary cirrhosis (PBC) is a chronic, autoimmune liver disease predominantly affecting middle-aged women.
- It is characterized by antimitochondrial antibodies (AMAs) and can progress to liver failure.
- While ursodeoxycholic acid (UDCA) improves survival, a third of patients do not respond and may require liver transplantation.
Purpose of the Study:
- To review the pathogenesis and current management of Primary Biliary Cirrhosis (PBC).
- To discuss the outcomes and challenges associated with liver transplantation for PBC, particularly disease recurrence.
- To analyze the current understanding of PBC recurrence post-liver transplantation.
Main Methods:
- Literature review of primary biliary cirrhosis (PBC) pathogenesis, treatment, and liver transplantation outcomes.
- Analysis of data regarding the prevalence, incidence, and impact of PBC recurrence after liver transplantation.
- Synthesis of current research on factors influencing PBC progression and post-transplant outcomes.
Main Results:
- Liver transplantation offers excellent survival rates for PBC patients (5-year: ~80%, 10-year: ~70%).
- Recurrence of PBC after liver transplantation is observed in 1-35% of cases, increasing with longer follow-up.
- Currently, PBC recurrence does not significantly impact patient or graft survival, and retransplantation is rare.
Conclusions:
- Liver transplantation is a successful treatment for end-stage PBC, but disease recurrence is a significant long-term consideration.
- Further research is needed to understand the long-term impact of recurrent PBC on graft and patient survival.
- Management strategies may need to evolve to address the increasing prevalence of recurrent PBC with extended patient follow-up.
Related Concept Videos
01:23Cirrhosis I: Introduction
22
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
22
01:26Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
01:24Cirrhosis II: Pathophysiology
24
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
01:28Kidney Transplant I: Introduction
808
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
808
01:26Kidney Transplant II: Surgical Procedure
899
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
899